Regional Delivery of Mesothelin-Targeted CAR T-Cell Therapy Creates a Win for Solid Tumors

Research presented at AACR 2019 evaluated  autologous mesothelin-targeted chimeric antigen receptor T-cell therapy in patients with malignant pleural disease.

Source: CancerNetwork - April 10, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news